The American Botanical Council says it’s planning for the future in seeking a new day-to-day chief executive as founder Mark Blumenthal shifts to a more advisory role.
A California bill to restrict the sale of weight management supplements has passed a key state legislative committee, increasing its chance eventually becoming law, trade associations have warned.
The history of the CBD trade in the US provides a peek into the strategy that kratom proponents may pursue with the goal of a legal trade in the botanical without regulatory impediments, an executive in an advocacy group says.
A St. Louis-based chiropractor and dietary supplement marketer faces monetary penalties for continuing to market vitamin D and zinc products that purport to prevent COVID-19 infections.
Rising demand in the contract manufacturing realm is driving both consolidation and pressure to make more transparent this sometimes closed section of the dietary supplement industry, observers say.
A recent paper claims FDA is in the dark as to how many new ingredients have come onto the market via the GRAS process. Only limited progress has been made in the decade since a Congressional report first raised the issue and directed the Agency to make...
The manufacturer of a multivitamin has withdrawn a number of claims relating to the purported benefits its product has for hyperactive children as part of a National Advertising Division case.
A warning letter sent to a Connecticut wholesaler about the sale of pure powdered caffeine points to the difficulty of keeping problematic products off the market in an environment in which hundreds of thousands of tons of cargo arrives in domestic ports...
Imagine taking the time and effort to cultivate hemp across hundreds of acres, only to find out that your harvest is contaminated. The damage can cause an odor, spoilage or significant illness to the end user if left unchecked.
Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.
